NCT06481124

Brief Summary

Pneumoperitoneum (PNP) and the position of the patient required for laparoscopic surgery lead to pathophysiological changes that complicate anesthesia. PNP is characterized by an increased intra-abdominal pressure (IAP), the cranial displacement of the diaphragm that can lead to the formation of intraoperative atelectasis and decrease end-expiratory lung volume (EELV). At the same time, PNP can reduce respiratory system compliance by 30-50% in healthy patients. During elective abdominal surgery under general anesthesia, atelectasis forms in almost 90% of patients and can become a focus of postoperative pneumonia. The negative effect of PNP is more prominent in Trendelenburg position. And one of the methods to avoid the effects of PNP and Trendelenburg position on lung tissue is to apply positive end-expiratory pressure (PEEP). PEEP is acknowledged as a component of lung protective ventilation (LPV) along with low tidal volume (TV) 6-8 ml/kg. On the other hand, excessive PEEP can lead to the overdistension of lung tissue and cause volutrauma and hemodynamic instability. It is necessary to use sufficient PEEP to minimize atelectasis, improve respiratory biomechanics and maintain oxygenation. Electrical impedance tomography shows changes in ventilation and perfusion during mechanical ventilation with the different PEEP levels. The study aimed to select optimum PEEP level based on optimum ventilation-to-perfusion match based on electrical impedance tomography measurements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 18, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

June 24, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 2, 2025

Status Verified

June 1, 2024

Enrollment Period

5 months

First QC Date

June 18, 2024

Last Update Submit

April 29, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Optimum positive end-expiratory pressure level by compliance win

    Positive end-expiratory pressure level selected by maximal compliance win measured by electrical impedance tomography

    40 minutes

  • Optimum positive end-expiratory pressure level by heart-lung index

    Positive end-expiratory pressure level selected by maximal heart-lung index measured by electrical impedance tomography

    40 minutes

Secondary Outcomes (10)

  • Compliance win

    3 minutes

  • Compliance loss

    3 minutes

  • Global inhomogeneity index

    3 minutes

  • Regional ventilation delay

    3 minutes

  • Lung-heart index

    3 minutes

  • +5 more secondary outcomes

Interventions

Measurement of ventilation and perfusion during mechanical ventilation with different positive end-expiratory pressure by electrical impedance tomography

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsGynecological surgery
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent elective gynecological operations in conditions of carboxyperitoneum with Trendelenburg position

You may qualify if:

  • Patients who undergo gynecological surgery under conditions of carboxyperitoneum in the Trendelenburg position.

You may not qualify if:

  • Pregnancy,
  • Hypoxemia before surgery (SpO2 \< 94%),
  • body mass index more than 35 kg/m2,
  • Unstable hemodynamics and/or life-threatening arrhythmia,
  • Primary or secondary lung diseases (COPD, interstitial lung diseases, metastatic lung disease)
  • Presence of an implantable pacemaker and/or defibrillator
  • Chronic diseases in the stage of decompensation with the development of extrapulmonary organ dysfunction (liver cirrhosis, progression of cancer, chronic heart failure).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Hospital 4, Sechenov University

Moscow, 119048, Russia

Location

Related Publications (5)

  • Andersson LE, Baath M, Thorne A, Aspelin P, Odeberg-Wernerman S. Effect of carbon dioxide pneumoperitoneum on development of atelectasis during anesthesia, examined by spiral computed tomography. Anesthesiology. 2005 Feb;102(2):293-9. doi: 10.1097/00000542-200502000-00009.

    PMID: 15681942BACKGROUND
  • Loring SH, Behazin N, Novero A, Novack V, Jones SB, O'Donnell CR, Talmor DS. Respiratory mechanical effects of surgical pneumoperitoneum in humans. J Appl Physiol (1985). 2014 Nov 1;117(9):1074-9. doi: 10.1152/japplphysiol.00552.2014. Epub 2014 Sep 11.

    PMID: 25213641BACKGROUND
  • Barbosa FT, Castro AA, de Sousa-Rodrigues CF. Positive end-expiratory pressure (PEEP) during anaesthesia for prevention of mortality and postoperative pulmonary complications. Cochrane Database Syst Rev. 2014 Jun 12;2014(6):CD007922. doi: 10.1002/14651858.CD007922.pub3.

    PMID: 24919591BACKGROUND
  • Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013 Nov 28;369(22):2126-36. doi: 10.1056/NEJMra1208707. No abstract available.

    PMID: 24283226BACKGROUND
  • Fahy BG, Barnas GM, Nagle SE, Flowers JL, Njoku MJ, Agarwal M. Changes in lung and chest wall properties with abdominal insufflation of carbon dioxide are immediately reversible. Anesth Analg. 1996 Mar;82(3):501-5. doi: 10.1097/00000539-199603000-00013.

    PMID: 8623951BACKGROUND

MeSH Terms

Conditions

Pneumoperitoneum

Condition Hierarchy (Ancestors)

Peritoneal DiseasesDigestive System Diseases

Study Officials

  • Andrey I Yaroshetskiy, MD, PhD, ScD

    Sechenov University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2024

First Posted

July 1, 2024

Study Start

June 24, 2024

Primary Completion

December 1, 2024

Study Completion

December 31, 2024

Last Updated

May 2, 2025

Record last verified: 2024-06

Locations